With approximately USD 24bn of capital under management and administration as of December 31, 2018, Antares
is a private debt credit manager and provider of financing solutions for middle-market private equity-backed transactions.
the Lloyd's managing agency and member of the QIC Group announced the appointment of Jonathan (Joe) Battle, the current active underwriter, as chief executive officer (subject to necessary regulatory approvals).
Fitch does not expect the debt issuance to have a material impact on the Antares
' leverage, as the firm's leverage ratio was below its targeted range of 2.5x to 3.0x at March 31, 2018.
The CEL5 can be configured as a top load, side-load, or bottom-load case packer, allowing greater flexibility in designing the packaging line that integrates easily with the Antares
Vision track-and-trace equipment.
Launched in December 2017, ABCS brings together Antares
' leadership position and expertise in supporting the financing needs of middle market private equity sponsors and borrowers with Bain Capital's 20-year track record of investing in middle market private debt.
is a massive star nearing the end of its life, with 15 times the mass, 883 times the girth, and 10,000 times the visible luminosity of our Sun.
is in the middle of the sky's scorpion constellation.
Sumatriptan Injection USP represents Antares
' first ANDA approval of a complex generic and second product approved using the VIBEX auto injector platform.
Orbital ATK's Antares
program remains on schedule to commence flight operations from Wallops in the first half of 2016.
This report provides comprehensive information on the current therapeutic developmental pipeline of Antares
Pharma, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
When asked if Antares
plans to appeal the decision either to the entire Federal Circuit or to the Supreme Court, Jack Howarth, vice president of Corporate Affairs at Antares
Pharma, responded to InsideCounsel, "The company does not comment on pending litigation."
was an ideal financing partner to help join these two companies.